Filing Details
- Accession Number:
- 0000891293-10-000032
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-09-02 19:14:10
- Reporting Period:
- 2010-08-31
- Filing Date:
- 2010-09-02
- Accepted Time:
- 2010-09-02 19:14:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 891293 | Cell Therapeutics Inc | CTIC | Pharmaceutical Preparations (2834) | 911533912 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1041084 | Phd M Phillip Nudelman | 501 Elliott Ave W, Suite 400 Seattle WA 98119 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-08-31 | 3,700 | $0.36 | 2,491,165 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-31 | 3,000 | $0.36 | 2,488,165 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-31 | 800 | $0.36 | 2,487,365 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-31 | 3,900 | $0.36 | 2,483,465 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-31 | 4,400 | $0.36 | 2,479,065 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-31 | 3,000 | $0.36 | 2,476,065 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-31 | 7,531 | $0.36 | 2,468,534 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-31 | 2,526 | $0.36 | 2,466,008 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-31 | 3,257 | $0.37 | 2,462,751 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-31 | 4,786 | $0.37 | 2,457,965 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-31 | 1,400 | $0.37 | 2,456,565 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-31 | 1,400 | $0.37 | 2,455,165 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-31 | 300 | $0.37 | 2,454,865 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Billionaire Hedge Funds
